Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates
Alex Laperle, Samuel Sances, Nur Yucer, et al.
Nature Medicine (2020) Vol. 26, Iss. 2, pp. 289-299
Closed Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease
Su‐Jeong Kim, Brendan Miller, Nicolas Hartel, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 505-517
Open Access | Times Cited: 6
Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection
Arun Sharma, Gustavo Garcia, Vaithilingaraja Arumugaswami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 45
An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells
Arnab Ray, Jahnavy Madhukar Joshi, Pradeep Kumar Sundaravadivelu, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 6, pp. 1954-1974
Closed Access | Times Cited: 37
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder
Ana Kolicheski, Pierpaolo Turcano, Nicole Tamvaka, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 8, pp. 2353-2367
Open Access | Times Cited: 27
The Genetic Drivers of Juvenile, Young, and Early‐Onset Parkinson's Disease in India
Shan V. Andrews, Prashanth Lingappa Kukkle, Ramesh Menon, et al.
Movement Disorders (2023) Vol. 39, Iss. 2, pp. 339-349
Open Access | Times Cited: 13
Single-Cell RNA Sequencing in Parkinson’s Disease
Shi‐Xun Ma, Su Bin Lim
Biomedicines (2021) Vol. 9, Iss. 4, pp. 368-368
Open Access | Times Cited: 30
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Jeswinder Sian‐Hülsmann, Peter Riederer
Cells (2021) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 27
From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities
Rebecca Mächtel, Fanni Annamária Boros, Jan Philipp Dobert, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167932-167932
Open Access | Times Cited: 21
Chronic and acute exposure to rotenone reveals distinct Parkinson's disease-related phenotypes in human iPSC-derived peripheral neurons
Mahmood Ali Saleh, Fatima Amer‐Sarsour, Asaf Berant, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 164-173
Open Access | Times Cited: 4
Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines
Negin Imani Farahani, Lisa Lin, Shama Nazir, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 18
Open Access
Single Cell Proteomics Reveals Specific Cellular Subtypes in Cardiomyocytes Derived from Human iPSCs and Adult Hearts
Lizhuo Ai, Aleksandra Binek, Vladimir Zhemkov, et al.
Molecular & Cellular Proteomics (2025), pp. 100910-100910
Open Access
Microfluidic tools to model, monitor, and modulate the gut–brain axis
Hyehyun Kim, Gregory Girardi, Allison Pickle, et al.
Biomicrofluidics (2025) Vol. 19, Iss. 2
Closed Access
Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia
Tingting Jia, Fan Yang, Fengqin Qin, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
iPSC for modeling neurodegenerative disorders
V. Valadez-Barba, Agustín Cota-Coronado, O.R. Hernández-Pérez, et al.
Regenerative Therapy (2020) Vol. 15, pp. 332-339
Open Access | Times Cited: 31
Dysfunction of vesicular storage in young-onset Parkinson's patient-derived dopaminergic neurons and organoids revealed by single cell electrochemical cytometry
Wanying Zhu, Mengdan Tao, Yuan Hong, et al.
Chemical Science (2022) Vol. 13, Iss. 21, pp. 6217-6223
Open Access | Times Cited: 16
Prediction of mechanistic subtypes of Parkinson’s using patient-derived stem cell models
Karishma D’Sa, James R. Evans, Gurvir S. Virdi, et al.
Nature Machine Intelligence (2023) Vol. 5, Iss. 8, pp. 933-946
Open Access | Times Cited: 9
Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation
Sina Hembach, Sebastian Schmidt, Tanja Orschmann, et al.
Neurobiology of Disease (2024) Vol. 194, pp. 106474-106474
Open Access | Times Cited: 3
Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
Ju‐Hee Kang, Jae Whan Kim, Hansol Heo, et al.
Clinical and Translational Science (2020) Vol. 14, Iss. 2, pp. 606-616
Open Access | Times Cited: 27
Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
Mark van den Hurk, Shong Lau, Maria C. Marchetto, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Effects of head trauma and sport participation in young-onset Parkinson’s disease
Tommaso Schirinzi, Piergiorgio Grillo, Giulia Di Lazzaro, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 8, pp. 1185-1193
Open Access | Times Cited: 17
Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114849-114849
Closed Access | Times Cited: 17
High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification
Aurore Vuidel, Loïc Cousin, Beatrice Weykopf, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 10, pp. 2349-2364
Open Access | Times Cited: 12
Defining Biomarkers in Stem Cell‐Derived Tissue Constructs for Drug and Disease Screening
Alexander R. Harris, Patrick McGivern, Frédéric Gilbert, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7113-7113
Open Access | Times Cited: 17
Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient
Nuno Jorge Lamas, Laurent Roybon
Frontiers in Drug Discovery (2021) Vol. 1
Open Access | Times Cited: 13

Scroll to top